# FDA Inspection 1263383 - McLaren Greater Lansing - February 28, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/mclaren-greater-lansing/0f884c11-5fdf-46b1-90a8-3ef25f6ff041
Source feed: FDA_Inspections

> FDA Inspection 1263383 for McLaren Greater Lansing on February 28, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1263383
- Company Name: McLaren Greater Lansing
- Inspection Date: 2025-02-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1263383 - 2025-02-28](https://www.globalkeysolutions.net/records/fda_inspections/mclaren-greater-lansing/c82c3ed3-d8d0-4f3a-9eb6-21bac26da4d5)
- [FDA Inspection 1080582 - 2018-11-28](https://www.globalkeysolutions.net/records/fda_inspections/mclaren-greater-lansing/5d4fca75-fb9c-4243-aaf2-18884994976d)
- [FDA Inspection 1001388 - 2017-02-07](https://www.globalkeysolutions.net/records/fda_inspections/mclaren-greater-lansing/8d45b46c-ff3f-4e98-aaef-fc5d3b8ceaea)
- [FDA Inspection 914643 - 2015-02-18](https://www.globalkeysolutions.net/records/fda_inspections/mclaren-greater-lansing/7328e16b-70fc-4410-9047-8590cbe8f13f)
- [FDA Inspection 824761 - 2013-03-28](https://www.globalkeysolutions.net/records/fda_inspections/mclaren-greater-lansing/b41361c4-10cc-4210-82d2-a37b1b8e00e6)

Company: https://www.globalkeysolutions.net/companies/mclaren-greater-lansing/9b38fae4-4b09-4e29-916d-f86d8af9e8f2

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d